siRNA therapeutics: insights, challenges, remedies and future prospects
Author:
Affiliation:
1. Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India
2. Department of Pharmaceutical Technology, Meerut Institute of Engineering and Technology, Meerut, Uttar Pradesh, India
Publisher
Informa UK Limited
Subject
Pharmaceutical Science
Link
https://www.tandfonline.com/doi/pdf/10.1080/17425247.2023.2251890
Reference159 articles.
1. Therapeutic siRNA: state of the art
2. Current status and future perspectives of gold nanoparticle vectors for siRNA delivery
3. Nanoparticle‐mediated siRNA delivery systems for cancer therapy
4. Current preclinical small interfering RNA (siRNA)-based conjugate systems for RNA therapeutics
5. Non-viral vectors for gene-based therapy
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Development of a multi-level pH-responsive lipid nanoplatform for efficient co-delivery of siRNA and small-molecule drugs in tumor treatment;Chinese Chemical Letters;2024-12
2. Exploring dose and downregulation dynamics in lipid nanoparticles based siRNA therapy: Systematic review and meta-analysis;International Journal of Biological Macromolecules;2024-10
3. Non-coding RNAs in Parkinson's disease: Regulating SNCA and alpha-synuclein aggregation;Pathology - Research and Practice;2024-09
4. Delivery of therapeutics with amylose-based nanosystems: A review;European Polymer Journal;2024-07
5. Graphene Oxide, a Prominent Nanocarrier to Reduce the Toxicity of Alzheimer’s Proteins: A Revolution in Treatment;Recent Patents on Nanotechnology;2024-05-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3